Process View
Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a STAT (Signal Transducer and Activator of Transcription) protein.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of tyrosine phosphorylation of stat protein"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
EGFR | epidermal growth factor receptor | 1.000 | Human | |
IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 1.000 | ||
ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 1.000 | Human | |
SOCS3 | suppressor of cytokine signaling 3 | 0.993 | ||
IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.989 | ||
CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.970 | ||
TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.955 | Human | |
IL6 | interleukin 6 (interferon, beta 2) | 0.946 | ||
TRAF1 | TNF receptor-associated factor 1 | 0.929 | ||
IL4R | interleukin 4 receptor | 0.924 | ||
JAK2 | Janus kinase 2 | 0.896 | Mouse | |
FGF1 | fibroblast growth factor 1 (acidic) | 0.850 | ||
PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.824 | ||
CCR5 | chemokine (C-C motif) receptor 5 | 0.816 | ||
LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.761 | ||
TRADD | TNFRSF1A-associated via death domain | 0.747 | ||
IGF1R | insulin-like growth factor 1 receptor | 0.735 | ||
CCL4 | chemokine (C-C motif) ligand 4 | 0.717 | Human | |
TNF | tumor necrosis factor | 0.706 | ||
CSH1 | chorionic somatomammotropin hormone 1 (placental lactogen) | 0.706 | Human | |
CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.704 | ||
GH1 | growth hormone 1 | 0.679 | ||
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.668 | ||
NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.664 | ||
ICAM1 | intercellular adhesion molecule 1 | 0.654 | ||
CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.639 | ||
FADD | Fas (TNFRSF6)-associated via death domain | 0.639 | ||
ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.626 | Human | |
VEGFA | vascular endothelial growth factor A | 0.607 | ||
TRAF5 | TNF receptor-associated factor 5 | 0.550 | ||
SYK | spleen tyrosine kinase | 0.547 | ||
STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.539 | ||
CCL8 | chemokine (C-C motif) ligand 8 | 0.467 | Human | |
IL23A | interleukin 23, alpha subunit p19 | 0.463 | ||
GRB2 | growth factor receptor-bound protein 2 | 0.463 | ||
CCL2 | chemokine (C-C motif) ligand 2 | 0.461 | Human | |
GAB1 | GRB2-associated binding protein 1 | 0.459 | ||
TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.448 | Human | |
PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.438 | ||
CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.409 | ||
PLCG1 | phospholipase C, gamma 1 | 0.394 | ||
IL1B | interleukin 1, beta | 0.394 | ||
CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.357 | ||
IL8 | interleukin 8 | 0.343 | ||
TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.315 | ||
CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.312 | ||
CSH2 | chorionic somatomammotropin hormone 2 | 0.300 | Human | |
CCL7 | chemokine (C-C motif) ligand 7 | 0.291 | Human | |
HDAC2 | histone deacetylase 2 | 0.276 | ||
TRAF2 | TNF receptor-associated factor 2 | 0.265 | ||
EPOR | erythropoietin receptor | 0.263 | ||
CFLAR | CASP8 and FADD-like apoptosis regulator | 0.262 | ||
IL10 | interleukin 10 | 0.253 | ||
STAT4 | signal transducer and activator of transcription 4 | 0.248 | ||
INSR | insulin receptor | 0.240 | ||
LAT | linker for activation of T cells | 0.224 | ||
JAK1 | Janus kinase 1 | 0.210 | ||
CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.207 | ||
SOCS1 | suppressor of cytokine signaling 1 | 0.201 | ||
CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.195 | ||
CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.185 | ||
NRP1 | neuropilin 1 | 0.184 | ||
CCL5 | chemokine (C-C motif) ligand 5 | 0.182 | ||
CAV1 | caveolin 1, caveolae protein, 22kDa | 0.181 | ||
TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.180 | Human | |
CSHL1 | chorionic somatomammotropin hormone-like 1 | 0.177 | Human | |
CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.170 | ||
IL2RG | interleukin 2 receptor, gamma | 0.168 | ||
GAB2 | GRB2-associated binding protein 2 | 0.166 | ||
GH2 | growth hormone 2 | 0.166 | Human | |
IGF2R | insulin-like growth factor 2 receptor | 0.164 | ||
CCL13 | chemokine (C-C motif) ligand 13 | 0.148 | Human | |
IRS1 | insulin receptor substrate 1 | 0.139 | ||
CCL11 | chemokine (C-C motif) ligand 11 | 0.137 | Human | |
CCR7 | chemokine (C-C motif) receptor 7 | 0.136 | ||
TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.134 | ||
SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.133 | ||
CSF1 | colony stimulating factor 1 (macrophage) | 0.126 | ||
IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | 0.115 | ||
WIPF1 | WAS/WASL interacting protein family, member 1 | 0.114 | ||
GHR | growth hormone receptor | 0.110 | ||
CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.109 | ||
CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.105 | Human | |
SELE | selectin E | 0.101 | ||
IDE | insulin-degrading enzyme | 0.094 | ||
STAT5A | signal transducer and activator of transcription 5A | 0.090 | ||
FGFR1 | fibroblast growth factor receptor 1 | 0.089 | Human | |
CCR1 | chemokine (C-C motif) receptor 1 | 0.088 | ||
CCL3 | chemokine (C-C motif) ligand 3 | 0.084 | Human | |
PGF | placental growth factor | 0.084 | ||
CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.083 | ||
VCAM1 | vascular cell adhesion molecule 1 | 0.083 | ||
CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.082 | ||
FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.081 | Human | |
CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.081 | ||
APP | amyloid beta (A4) precursor protein | 0.078 | ||
PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.076 | ||
CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.075 | ||
UBASH3B | ubiquitin associated and SH3 domain containing B | 0.072 | ||
CCL22 | chemokine (C-C motif) ligand 22 | 0.070 | ||
SLA | Src-like-adaptor | 0.070 | ||
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.070 | Human | |
PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.069 | ||
TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.067 | ||
CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 0.066 | ||
CCL19 | chemokine (C-C motif) ligand 19 | 0.062 | Human | |
KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.062 | ||
LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.061 | ||
LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.059 | ||
RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.059 | ||
DPP4 | dipeptidyl-peptidase 4 | 0.057 | ||
OSMR | oncostatin M receptor | 0.057 | Human | |
IL6R | interleukin 6 receptor | 0.057 | ||
FGFR2 | fibroblast growth factor receptor 2 | 0.055 | Human | |
KRT8 | keratin 8 | 0.052 | ||
CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.046 | ||
SOS1 | son of sevenless homolog 1 (Drosophila) | 0.045 | ||
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.044 | Human | |
STAT1 | signal transducer and activator of transcription 1, 91kDa | 0.043 | ||
IL1R1 | interleukin 1 receptor, type I | 0.043 | ||
KITLG | KIT ligand | 0.043 | ||
FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.043 | ||
FGF10 | fibroblast growth factor 10 | 0.042 | ||
IFNG | interferon, gamma | 0.041 | ||
LIFR | leukemia inhibitory factor receptor alpha | 0.040 | Human | |
FGF7 | fibroblast growth factor 7 | 0.040 | ||
FRS2 | fibroblast growth factor receptor substrate 2 | 0.040 | ||
CSF3 | colony stimulating factor 3 (granulocyte) | 0.039 | ||
SNAP23 | synaptosomal-associated protein, 23kDa | 0.038 | ||
IL1A | interleukin 1, alpha | 0.038 | ||
CCL20 | chemokine (C-C motif) ligand 20 | 0.038 | Human | |
NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.037 | ||
CMIP | c-Maf-inducing protein | 0.037 | ||
CD28 | CD28 molecule | 0.036 | ||
IL13 | interleukin 13 | 0.035 | ||
OSM | oncostatin M | 0.035 | ||
SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.035 | ||
BCL2A1 | BCL2-related protein A1 | 0.035 | ||
CH25H | cholesterol 25-hydroxylase | 0.034 | ||
CD14 | CD14 molecule | 0.033 | ||
MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.032 | ||
FGF2 | fibroblast growth factor 2 (basic) | 0.032 | ||
ARRB1 | arrestin, beta 1 | 0.032 | ||
DARC | Duffy blood group, chemokine receptor | 0.031 | ||
BCL2 | B-cell CLL/lymphoma 2 | 0.031 | ||
PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.031 | ||
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.031 | ||
MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.030 | ||
HCK | hemopoietic cell kinase | 0.030 | ||
JAK3 | Janus kinase 3 | 0.030 | ||
MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.030 | ||
TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.030 | ||
TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.030 | ||
PTPRB | protein tyrosine phosphatase, receptor type, B | 0.030 | ||
ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B | 0.029 | ||
CNTF | ciliary neurotrophic factor | 0.029 | ||
UBD | ubiquitin D | 0.028 | ||
IL9 | interleukin 9 | 0.027 | ||
SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.026 | ||
LDLR | low density lipoprotein receptor | 0.026 | ||
PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.025 | ||
HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.025 | ||
ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.025 | ||
IL7R | interleukin 7 receptor | 0.025 | ||
TNFRSF13B | tumor necrosis factor receptor superfamily, member 13B | 0.025 | ||
FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.025 | ||
CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.025 | ||
CD83 | CD83 molecule | 0.024 | ||
PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.023 | ||
EXT1 | exostosin 1 | 0.023 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.023 | ||
CCR4 | chemokine (C-C motif) receptor 4 | 0.022 | ||
IL2RB | interleukin 2 receptor, beta | 0.022 | ||
DLG4 | discs, large homolog 4 (Drosophila) | 0.022 | ||
CD2 | CD2 molecule | 0.022 | ||
AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.021 | ||
ICA1 | islet cell autoantigen 1, 69kDa | 0.021 | ||
TNFSF14 | tumor necrosis factor (ligand) superfamily, member 14 | 0.021 | ||
STC1 | stanniocalcin 1 | 0.021 | ||
PECAM1 | platelet/endothelial cell adhesion molecule | 0.021 | ||
BBS10 | Bardet-Biedl syndrome 10 | 0.021 | ||
BCL3 | B-cell CLL/lymphoma 3 | 0.021 | ||
TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.021 | ||
IFNB1 | interferon, beta 1, fibroblast | 0.020 | Human | |
APOE | apolipoprotein E | 0.020 | ||
LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.020 | ||
INHBA | inhibin, beta A | 0.020 | ||
PLEK | pleckstrin | 0.019 | ||
RGS1 | regulator of G-protein signaling 1 | 0.019 | ||
GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.019 | ||
PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.019 | ||
VAV1 | vav 1 guanine nucleotide exchange factor | 0.019 | ||
IL1RN | interleukin 1 receptor antagonist | 0.019 | ||
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.019 | ||
VEGFC | vascular endothelial growth factor C | 0.019 | ||
IDO1 | indoleamine 2,3-dioxygenase 1 | 0.019 | ||
ITGB1BP1 | integrin beta 1 binding protein 1 | 0.019 | ||
FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.019 | ||
TIFA | TRAF-interacting protein with forkhead-associated domain | 0.019 | ||
KYNU | kynureninase | 0.018 | ||
IRF4 | interferon regulatory factor 4 | 0.018 | ||
AXL | AXL receptor tyrosine kinase | 0.018 | ||
NNMT | nicotinamide N-methyltransferase | 0.018 | ||
C3 | complement component 3 | 0.017 | ||
CD7 | CD7 molecule | 0.017 | ||
TLR3 | toll-like receptor 3 | 0.017 | ||
GGA2 | golgi-associated, gamma adaptin ear containing, ARF binding protein 2 | 0.017 | ||
STAB1 | stabilin 1 | 0.017 | ||
PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.017 | ||
FAF1 | Fas (TNFRSF6) associated factor 1 | 0.017 | ||
IL2 | interleukin 2 | 0.017 | ||
TRAF3IP2 | TRAF3 interacting protein 2 | 0.017 | ||
GRB7 | growth factor receptor-bound protein 7 | 0.016 | ||
EBI3 | Epstein-Barr virus induced 3 | 0.016 | Human | |
FYN | FYN oncogene related to SRC, FGR, YES | 0.016 | ||
ARL2 | ADP-ribosylation factor-like 2 | 0.016 | ||
IL1R2 | interleukin 1 receptor, type II | 0.016 | ||
IL21R | interleukin 21 receptor | 0.016 | ||
CCL1 | chemokine (C-C motif) ligand 1 | 0.016 | ||
IL11 | interleukin 11 | 0.016 | ||
GGA1 | golgi-associated, gamma adaptin ear containing, ARF binding protein 1 | 0.016 | ||
NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.016 | ||
VHL | von Hippel-Lindau tumor suppressor | 0.016 | ||
PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.016 | ||
FOSL1 | FOS-like antigen 1 | 0.016 | ||
C1R | complement component 1, r subcomponent | 0.016 | ||
IL5 | interleukin 5 (colony-stimulating factor, eosinophil) | 0.016 | ||
C2 | complement component 2 | 0.016 | ||
CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.015 | ||
MSC | musculin | 0.015 | ||
EPHA2 | EPH receptor A2 | 0.015 | ||
PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.015 | ||
IL2RA | interleukin 2 receptor, alpha | 0.015 | ||
FGFR3 | fibroblast growth factor receptor 3 | 0.015 | ||
ADAMDEC1 | ADAM-like, decysin 1 | 0.014 | ||
CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.014 | ||
RGS16 | regulator of G-protein signaling 16 | 0.014 | ||
IFNA16 | interferon, alpha 16 | 0.014 | Human | |
HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.014 | ||
DCN | decorin | 0.014 | ||
CSNK1E | casein kinase 1, epsilon | 0.014 | ||
PIK3CB | phosphoinositide-3-kinase, catalytic, beta polypeptide | 0.014 | ||
FASLG | Fas ligand (TNF superfamily, member 6) | 0.014 | ||
IL18R1 | interleukin 18 receptor 1 | 0.014 | ||
PTEN | phosphatase and tensin homolog | 0.014 | ||
XCL2 | chemokine (C motif) ligand 2 | 0.013 | ||
IL12RB1 | interleukin 12 receptor, beta 1 | 0.013 | ||
CCR3 | chemokine (C-C motif) receptor 3 | 0.013 | ||
HAS2 | hyaluronan synthase 2 | 0.013 | ||
PDGFA | platelet-derived growth factor alpha polypeptide | 0.013 | ||
PIK3CD | phosphoinositide-3-kinase, catalytic, delta polypeptide | 0.013 | ||
ZMYND11 | zinc finger, MYND-type containing 11 | 0.013 | ||
ZBTB48 | zinc finger and BTB domain containing 48 | 0.013 | ||
SLAMF7 | SLAM family member 7 | 0.013 | ||
HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.013 | ||
GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.013 | ||
CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.012 | ||
IL12RB2 | interleukin 12 receptor, beta 2 | 0.012 | Human | |
BID | BH3 interacting domain death agonist | 0.012 | ||
IFNA4 | interferon, alpha 4 | 0.012 | ||
CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.012 | ||
TRO | trophinin | 0.012 | ||
NKG7 | natural killer cell group 7 sequence | 0.012 | ||
FPR3 | formyl peptide receptor 3 | 0.012 | ||
C3AR1 | complement component 3a receptor 1 | 0.012 | ||
ABL2 | v-abl Abelson murine leukemia viral oncogene homolog 2 | 0.012 | ||
KHDRBS1 | KH domain containing, RNA binding, signal transduction associated 1 | 0.012 | ||
C1QA | complement component 1, q subcomponent, A chain | 0.012 | ||
RUNX3 | runt-related transcription factor 3 | 0.012 | ||
TGFB3 | transforming growth factor, beta 3 | 0.012 | ||
FAS | Fas (TNF receptor superfamily, member 6) | 0.012 | Human | |
PTX3 | pentraxin 3, long | 0.011 | ||
TGFB1 | transforming growth factor, beta 1 | 0.011 | ||
CCL17 | chemokine (C-C motif) ligand 17 | 0.011 | ||
ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.011 | ||
DAXX | death-domain associated protein | 0.011 | ||
CELA3B | chymotrypsin-like elastase family, member 3B | 0.011 | ||
ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.011 | ||
C1QB | complement component 1, q subcomponent, B chain | 0.011 | ||
TRAF6 | TNF receptor-associated factor 6 | 0.011 | ||
EDN1 | endothelin 1 | 0.011 | ||
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.011 | ||
DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.011 | ||
CD22 | CD22 molecule | 0.011 | ||
TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 0.011 | ||
MPEG1 | macrophage expressed 1 | 0.011 | ||
FANCD2 | Fanconi anemia, complementation group D2 | 0.011 | ||
CCL23 | chemokine (C-C motif) ligand 23 | 0.011 | Human | |
TNC | tenascin C | 0.011 | ||
HSPA6 | heat shock 70kDa protein 6 (HSP70B') | 0.011 | ||
CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.011 | ||
XCL1 | chemokine (C motif) ligand 1 | 0.010 | Human | |
IL32 | interleukin 32 | 0.010 | ||
RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.010 | ||
TLR2 | toll-like receptor 2 | 0.010 | ||
MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.010 | ||
RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.010 | ||
SPSB1 | splA/ryanodine receptor domain and SOCS box containing 1 | 0.010 | ||
GCG | glucagon | 0.010 | ||
CD40LG | CD40 ligand | 0.010 | ||
MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.010 | ||
NUDT3 | nudix (nucleoside diphosphate linked moiety X)-type motif 3 | 0.010 |